M edical societies have recommended the evaluation of pain and agitation levels and the titration of sedative and analgesics drugs in intensive care unit (ICU) patients (1, 2) consistent with the Joint Commission on Accreditation of Healthcare Organization's standards (3, 4) . Based on the European survey (5), of the 43% of ICUs that do use sedation scales, 74% use the Ramsay scale although this scale does not evaluate agitation states (6, 7) . Management of pain seems to also be insufficient. Painful procedures were performed after administration of an analgesic in Ͻ20 -40% (8, 9) . ICU physicians are certainly uncomfortable treating pain appropriately (10) because of organ system dysfunction, impaired mental status, and altered pharmacokinetics and pharmacodynamics apropos of the critically ill population. Specifically, this population is more susceptible to the side effects of analgesics or sedative drugs (vasoplegia, respiratory depression, inhibition of cough, constipation, vigilance impairment). Analgesics can be associated with adverse events. It has been reported that they can be associated with an increased length of ventilation and stay in the ICU (11) .
Surprisingly, there are no published studies about the impact of a systematic evaluation of pain and agitation in ICU, as recommended in official practice guidelines (1) (2) (3) 7) .
We conducted the present before-after study to test the hypothesis that implementation of a systematic evaluation of pain and agitation by nurse following by a medical intervention in an ICU would be associated with a decrease in the incidence and intensity of pain and agitation.
MATERIALS AND METHODS

Population
The present before-after study took place in the 12-bed medical-surgical ICU of the St Eloi Hospital, a 660-bed teaching and referral facility of the University of Montpellier in France, staffed by 35 nurses, 20 assistant nurses, five physicians, and three residents. All consecutive patients Ն18 yrs old and staying in the ICU for Ͼ24 hrs were eligible. Only the first admission in the ICU was included during each phase. Exclusion criteria were decision to withdraw life support within 48 hrs after admission, brain injuries that limited communication by the patient, transfer to another ICU for specialized care, and stay in the ICU during both phases of the study.
Ethics and Consent
The Ethics Committee of the French Society of Critical Care waived the need for informed consent.
Study Design
Control Phase. During the control phase (from November 2002 to March 2003, 21 wks) no systematic and objective evaluation of pain or agitation was done by nurses or physicians. Six independent observers (students in medicine and pharmacy) evaluated pain and agitation levels among all the patients admitted in the unit (tools described subsequently). This evaluation occurred at rest, 30 mins after any procedure, between the times of 0800 and 1000 hrs, and between 2000 and 2200 hrs. Nurses and treating physicians were blinded to the results of pain and agitation evaluations. The same instructor (GC) performed a standardized individual training for observers at the bedside on ten patients. Then they were tested for reliability in 43 patients during 10 evaluation days (October 2002). Intraclass coefficient correlation was .97 (upper 95th percent confidence limit, .99) for the Richmond Agitation Sedation Scale (RASS) and .81 (.93) for the Behavioral Pain Scale (BPS).
Interphase. Physicians and residents received an oral education and a written support (Appendix 1) that encouraged them to vigorously assess and treat pain and/or agitation after recognition of a significant event by nurses using a systematic approach: confirm the presence of pain/agitation, diagnose the source, choose the appropriate analgesic/ psychoactive drug, and consider the riskbenefit ratio of drug administration according to each clinical situation. Treatment was ordered only by the treating physician. On daily rounds (between the times of 1000 and 1300 hrs and between 2200 and 0100 hrs), physicians considered the necessity to maintain analgesic and/or psychoactive treatments and were encouraged to decrease doses to the minimal effective dose (Appendix 1). During 4 wks (March 2003) the 35 nurses were trained individually at the bedside by the same instructor to evaluate pain and agitation levels in the same way as that done by the control phase observers.
Intervention Phase. During the intervention phase (from April to October 2003, 29 wks), bedside nurses evaluated pain and agitation levels among all the patients admitted to the ICU. This evaluation occurred at rest, 30 mins after any procedure, between the times of 0800 and 1000 hrs, between 1400 and 1600 hrs, and between 2000 and 2200 hrs, such that each nursing shift had an identified 2-hr period during which assessments were done. Nurses could perform additional evaluations at any time of the day or night and during painful procedures. The physician was promptly notified of a pain or an agitation event, regardless of the hour. Information about these evaluations was communicated during each daily meeting between nurses and physicians. Nurses began the clinical presentation of their patient with evaluation of pain and agitation levels, which could be considered as a "vital sign" (4) along with usual vital signs (heart rate, blood pressure, respiratory rate, oximetry, urine output, and body temperature). Education performed during the interphase was continued during daily meeting between nurses and physicians.
Evaluation of Pain and Agitation. Choice of pain and agitation evaluation tools was performed after review of the literature (2, 12, 13) and pilot tests. The pain evaluation tool used was the 0 -10 numerical relative scale (NRS, appendix 2) (12). This scale was adapted to ICU patients, who often suffer from sensorial deficiencies; therefore, the printed scale was enlarged to be easily visible (3.9 ϫ 11.8 inches). The BPS (Appendix 2) (14) was used for evaluation of pain in intubated patients if they were not able to perform the NRS.
Two hundred and twenty evaluations were performed independently during a period Ͻ1 hr on 38 patients to measure the reliability between independent observers and nurses. The RASS (Appendix 2) (15, 16) was used to evaluate the agitation level. A French translated version, which had been validated previously (17), was used. Intraclass coefficient correlation was .96 (upper 95th percent confidence limit, .97) for the RASS, .86 (.91) for the BPS, and .90 (.94) for the NRS. Reliability of NRS was tested because patients could worry about pain differently with nurses than with independent observers.
A pocket-card was given to control phase observers and intervention phase nurses after training. Laminated plastic posters with the large-print ICU-adapted NRS were placed on the wall of each room. All of these tools were approved by the infection control department of Montpellier University Hospital according to usual guidelines (18) and created by the communications department of the hospital. No financial support was provided by pharmaceutical industries.
A pain event was defined by either a BPS score Ͼ5 (14) or a NRS level Ͼ3 (12). An agitation event was defined by a RASS level Ͼ1 (15, 16) .
Weaning Practices. Weaning practices did not differ between the two phases for patients who required mechanical ventilation. Patients were considered candidates for weaning when they no longer had high-grade fever, hemodynamic instability, or severely altered consciousness, as well as exhibiting adequate oxygenation with an FIO 2 50% and positive endexpiratory pressure Ͻ5 cm H 2 O.
Candidates for weaning were switched to pressure support ventilation and underwent daily spontaneous breathing trials on a T piece.
Decision to extubate was based on simple bedside tolerance variables, including respiratory rate, SpO 2 , and the use of accessory respiratory muscles during T-piece trials.
Data Collection
Data were prospectively recorded during both phases of the study. Age, gender, type of admission, and the Simplified Acute Physiology Score II (19) were collected within 24 hrs after admission. Medical admission was defined by the absence of surgical intervention. Planned surgery was defined by admission to the ICU immediately after a surgical intervention that was planned Ն24 hrs in advance. Unplanned surgery was defined by admission to the ICU immediately after an unplanned intervention. Postoperative complication was defined by an admission from surgical ward to the ICU without prior reintervention. Number and level of events of pain and agitation were recorded daily during the two periods of evaluation common to both phases: at rest, between the times of 0800 and 1000 hrs, and between 2000 and 2200 hrs. The median observation rate of the systematic evaluation of pain and agitation levels during both phases was defined as follows: median of (the number of evaluations done between the times of 0800 and 1000 hrs and between 2000 and 2200 hrs ϫ 100/the number of evaluations which should have been done, i.e., the length of stay in the ICU ϫ 2). Severe pain events were defined by either a BPS score Ͼ7 or an NRS level Ͼ6 (12) . Severe agitation events were defined by a RASS level Ͼ2 (15) . Throughout the period of stay in the ICU, we recorded the day and time of initiation of mechanical ventilation; day and time of end of mechanical ventilation, which was considered the day the patient was extubated, provided that there was no need for reintubation within the next 48 hrs; day and time of initiation of intravenous continuous sedation; type of psychoactive drugs and analgesics classified according the three levels of the World Health Organization (WHO); daily dose of continuous intravenous sedation (midazolam or propofol Ϯ fentanyl or morphine); total dose of other intravenous psychoactive drugs and analgesics; number of therapeutic changes in the way of an escalation defined by an administration of a new drug and/or an increase of Ն20% of the daily dose; and number of therapeutic changes in the way of a de-escalation defined by an interruption of a drug and/or a decrease of Ն20% of the daily dose. Throughout the stay in ICU, we recorded the occurrence of adverse events: surgical reintervention, myocardial ischemia, thromboembolic event, intestinal occlusion requiring surgery or colo-aspiration, self-extubation, and self-removal of central venous catheter, bladder catheter, or gastric tube. At time of discharge we collected the first day of intestinal transit, the maximal amount of daily gastric residuals, and data related to nosocomial infections expressed as the ratio of nosocomial infections to the number days exposed to the risk and the number of patients having a nosocomial infection (ventilator-acquired pneumonia: at least one organism isolated by bronchoalveolar lavage at a concentration Ն10 4 colony-forming units (CFU)/mL; colonization of central venous catheters: at least one organism at a concentration Ն10
3 CFU/mL identified by a culture of the catheter tip via the Brun-Buisson technique (20) ; urinary catheter related infection: the association of a leukocyturia at a concentration of Ն10 4 mL with the presence of an organism at a concentration of 10 5 CFU/mL; bacteremia: a positive hemoculture with the isolation of an organism or at least two positive hemocultures for a coagulase-negative Staphylococcus according to the usual definitions (21) . Length of stay and mortality in the ICU were recorded.
Questionnaire
A questionnaire was administered anonymously to nurses and assistant nurses before and after intervention phase. They were asked to quantify the quality of pain and agitation management in the ICU (inadequate, moderate, well, or very well) and to specify the contributing factors that should be improved.
End Points
The primary end point was the incidence of pain defined by the proportion of patients who developed at least one pain event (BPS Ͼ5 and/or NRS Ͼ3) and the incidence of agitation defined by the proportion of patients who developed at least one agitation event (RASS Ͼ1) during their ICU stay, at rest, between the times of 0800 and 1000 hrs and between 2000 and 2200 hrs. Secondary end points were a) the duration of mechanical ventilation, length of stay, adverse outcomes, and mortality in ICU; b) changes in analgesics and psychoactive prescriptions practices; and c) nurse satisfaction with pain and agitation management in the ICU.
Statistical Analysis
With an incidence of pain of 60% and agitation of 30%, the sample size needed to show a 30% reduction of incidence of pain or agitation, with ␣ and ␤ errors of .05 and .20, respectively, would be 99 analyzable patients in each study period. Considering ineligible patients, this translated to 120 admitted patients in each phase of 5 months.
Quantitative data were shown as medians and 25th-75th percentiles. Mann-Whitney U test (quantitative data) and Fisher's test (qualitative data) were used to compare patients included in the control phase (control group) to those in the intervention phase (intervention group). Relative risks to not develop a pain or an agitation event, associated with intervention, were calculated and expressed with their 95% confidence limits. We considered p Յ .05 to be statistically significant. Data were analyzed using the SAS software version 6.12 (SAS Institute, Cary, NC). The Department of Medical Statistics of the Montpellier University Hospital performed statistical analysis.
RESULTS
Two hundred and ninety five patients were admitted during the period of the study. During the control phase, 122 patients were admitted a total of 125 times in the ICU. Seventeen patients were not included because they stayed Ͻ24 hrs in the ICU. Five patients were excluded because of a decision to withdraw life support within 48 hrs after admission (n ϭ 2), impossible communication (n ϭ 1), transfer to another ICU (n ϭ 1), or stay in The median observation rate of the systematic evaluation of pain and agitation levels during both phases was defined as follows: median of (the number of evaluations done between the times of 0800 and 1000 hrs and between 2000 and 2200 hrs ϫ 100/the number of evaluations that should have been done, i.e. the length of stay in the ICU ϫ 2). No significant difference was observed in the rate of BPS ratings among pain ratings (BPS and NRS) performed in ventilated patients during their ICU stay (39. Quantitative data were expressed in median (25th-75th percentiles).
the ICU during both phases (n ϭ 1). During the intervention phase, 173 patients were admitted a total of 180 times in the ICU. Thirty-four patients were not included because they stayed Ͻ24 hrs in the ICU. Six patients were excluded because of a decision to withdraw life support within 48 hrs after admission (n ϭ 5) or impossible communication (n ϭ 1). Three patients were not included because of missing data. Thus, a total of 230 patients were included for analysis: 100 patients admitted 100 times (control group) and 130 patients admitted 130 times (intervention group).
Patients characteristics of the two groups were similar ( Table 1 ). The median observation rate of systematic evaluation of pain and agitation was significantly higher in the intervention group than in the control group (Table 2) .
However, compared with the control group, the incidence of pain and agitation was significantly lower in the intervention group: 63 vs. 42% (p ϭ .002) and 29 vs. 12% (p ϭ .002), respectively (Fig. 1) . In the intervention group, the relative risk to not develop a pain event was 1.44 (1.14, 1.81) and the relative risk to not develop an agitation event was 1.73 (1.15, 2.61). The incidence of severe pain defined by an NRS level Ͼ6 or a BPS level Ͼ7 and severe agitation defined by a RASS level Ͼ2 were significantly lower in the intervention group: 36 vs. 16% (p Ͻ .001) and 18 vs. 5% (p ϭ .002), Rate of pain evaluated by BPS among patients who developed a pain event was not significantly different between the two groups: 14 of 63 (22%) vs. ten of 55 (18%), p ϭ .65, respectively.
Among pain and agitation events, the rate of severe pain events evaluated by an NRS level Ͼ6 and the rate of severe agitation events evaluated by a RASS level Ͼ2 were significantly lower in the intervention group: 57 of 176 vs. 24 of 168 events (p Ͻ .001) and 42 of 82 vs. 9 of 31 events (p ϭ .03) respectively (Fig. 2) . The rate of severe pain events evaluated by a BPS level Ͼ7 was not significantly different between the two groups: 12 of 38 vs. four of 17 (p ϭ .75, Fig. 2 ).
Main adverse events are shown in Table 3 and nosocomial infections in Table  4 . Compared with the control group, there was a marked decrease in duration of mechanical ventilation and nosocomial infections rate in the intervention group (Tables 3 and 4 ). There was no significant difference in median length of stay and mortality in ICU between the two groups (Table 3) .
Among the analgesic and sedative drugs used during the two phases, tramadol was the only drug used significantly more frequently in the intervention group (16 vs. 27%, p ϭ .05). There was no significant difference among drugs used for continuous sedation in the two groups. Midazolam, propofol, or either was used for continuous sedation respectively in 87%, 7%, and 6% in control group vs. 74%, 16%, and 10% in the intervention group (p ϭ .18). Fentanyl, morphine, or either was used for continuous sedation respectively in 89%, 2%, and 9% in control group vs. 80%, 8%, and 12% in the intervention group (p ϭ .31). The dose of morphine administered as continuous sedation showed a trend to be higher in the intervention group: 0. (control group, 38 events; intervention group, 17) or a NRS Ͼ3 (control group, 176 events; intervention group, 168) and significant agitation events defined by a RASS Ͼ1 (control group, 82 events; intervention group, 31). NS, not significantly different. *p Ͻ .05. ***p Ͻ .001.
There were more therapeutic changes in the intervention group in the way of an escalation but also in the way of a deescalation for third WHO level analgesics, centrally acting muscle relaxants, spasmolytic intestinal and nonsteroid antiinflammatory drugs, neuroleptics, and clonidine (Table 5) .
Twenty-five nurses answered the questionnaire before the intervention phase and 32 after. Rate of satisfaction and contributing factors of dissatisfaction with pain and agitation management are shown in Figures 3 and 4. 
DISCUSSION
The main finding of our study is that systematic evaluation of pain and agitation levels by nurses with rapid call to a physician in case of pain or agitation decreased the observed incidence and intensity of pain and agitation in ICU patients. This improvement in pain and agitation management was associated with a better outcome (shorter duration of mechanical ventilation and lower nosocomial infections rate). These results could be explained by a better match between analgesic and psychoactive drugs and patients' needs for these drugs. Education of physicians and daily meeting between nurses and physicians reinforced the importance of rapid physician response to nurses' calls and vigorous evaluation and treatment of the reported pain and agitation. Medical intervention delay, the main cause of nurse dissatisfaction with pain and agitation management, decreased markedly after intervention, as expected (Fig. 4) . However, treatments should be ordered with caution, adapted to the minimal efficient dose, and stopped if unnecessary. This study constitutes an improvement project in quality and safety in health care (22, 23) . Importance of this project is highlighted by the high incidence of pain (63%) and agitation (29%) in the control group. The decrease of the stress response associated with pain and agitation, characterized by tachycardia, increased myocardial oxygen consumption, hypercoagulability, immunosuppression, and persistent catabolism (24, 25) , could explain in part the better outcome associated with the intervention group. Actually, it was suggested that the combined use of analgesics and sedatives could ameliorate the stress response in critically ill patients (26, 27) .
However, decrease of duration of mechanical ventilation and rate of nosocomial infections should be explained especially by physician education, which encouraged them to stop or decrease analgesics or psychoactive drug administration in the absence of pain or agitation (Appendix 1). Implementation of a systematic evaluation of pain and agitation allowed providers to screen for the absence of pain or agitation and therefore to decrease or discontinue administration of analgesic or psychoactive drugs during the two daily rounds of physicians.
There were few differences between the groups with regard to the types of medications used. However, higher doses of morphine, clonidine, and phlorogucinol were used in the intervention group.
The number of therapeutic changes in the way of an escalation but also in the way of a de-escalation in many analgesic and psychoactive drugs increased during the intervention phase to better meet patients' needs. These findings are similar to those observed after introduction of a sedation algorithm based on a semiquantitative scale (28 -30) . There were several differences between our study and these previous studies. First, all patients who stayed Ͼ24 hrs in our ICU were included in the present study, contrary to previous studies that included only sedated and mechanically ventilated patients. This is the first study to our knowledge that evaluated the impact of implementation of .01 Number of reintubations, n (%) 6 (10) 7 (7) .77 Surgical reintervention, n (%) 6 (10) 7 (9) .77 Upper gastrointestinal hemorrhage, n (%) 3 (3) 2 (2) .65 Thromboembolic event, n (%) 4 (4) 3 (2) .47 Myocardial ischemia, n (%)
12 (12) 9 (7) . 25 12 (12) 19 (15) .76
ICU, intensive care unit. Quantitative data were expressed as median (25th-75th percentiles). the RASS, which is the only agitation scale validated in a large population of ventilated and nonventilated and sedated and nonsedated ICU patients. Second, this is the first study to our knowledge that evaluated the impact of implementation of specific tools allowed to evaluate pain in communicative and also in noncommunicative patients. To our knowledge, there are no published data regarding a systematic assessment of pain and agitation levels in order to improve pain and agitation management in the ICU. In addition, the incidence of these events is not well known in ICU patients due to a paucity of precise published data (7). The incidence of pain has been reported during a painful procedure (31-33) but surprisingly, there are no data published concerning incidence of pain at rest. A reported incidence of pain and bothersome psychological memories of 30 -50% after ICU discharge (34, 35) suggests the potential for improved symptom management, which could contribute to a less stressful ICU stay and improved patient outcomes. Impact of these events on the posttraumatic stress disorder occurrence is likely (36) . Recent studies that evaluated the quality of life after an ICU stay (37, 38) showed that 44% of patients had more discomfort or pain 18 months after ICU discharge than before ICU admission (37) and that pain was worse 6 yrs after ICU discharge compared with general population controls (38) . In addition, the level of pain experienced in hospital is strongly associated with the level of pain experienced 6 months after discharge among seriously ill patients (39) . There are very few data available about agitation in the ICU. An incidence of 16% of severe agitation defined as two or more Motor Activity Assessment Scale levels Ͼ4 in a 24-hr period and sedative and/or narcotic doses above a established sedation and analgesia protocol or a combination of two or more sedatives has been reported in a ventilated medical ICU population (40) . Screening for agitation by reading the nurses' notes, we reported in a previous study an agitation incidence of 52% in a ventilated/nonventilated medicalsurgical ICU population (41) . The lower incidence of agitation in the control group of the present study (29%) could be explained by a different definition of incidence and agitation but also by an awareness of the staff between the two studies (3 yrs). Agitation in ICU was associated with adverse outcomes including longer duration of mechanical ventilation (40) , prolonged stay (40, 41) , nosocomial infections (41), and unplanned extubations (40, 41) .
Our study has several limitations. First, patients were not randomized. However, study was performed using a sequential study of two closely related time periods in which all consecutive patients were screened for enrollment in the study. This design was appropriate to test the study hypothesis because it was essential to prevent contamination of groups through use of systematic objective evaluation of pain and agitation in the control patients (42) . Second, the observation rate of the evaluation of pain and agitation was significantly higher in the second phase. Because of a student-topatient ratio lower than the nurse-topatient ratio (1-2 to 12 vs. 1 to 3), students could not evaluate all the patients because of an occasional high charge of work during the control phase. This reinforced the results because the incidence of pain and agitation was lower in the second group. Moreover, the median observation rate of pain was lower than agitation. Other pain evaluation tools should be developed for nonventilated ICU patients who are unable to communicate. Third, the incidence and intensity of pain and agitation events were ob- served only at rest. A prolonged presence of independent observers during the day and night was not possible during the first phase. We may have missed additional episodes of pain and agitation during these periods.
Fourth, clonidine was ordered in case of agitation, but its analgesic effect (43) was not evaluated. Fifth, we did not use specific ICU tools to assess the neuropsychological compound of pain and agitation (12) , such as the recently validated Confusion Assessment Method for the ICU (44) . This tool, which assists in the determination of delirium by nurses, has not yet been validated in a French ICU, where the average nurse to patient ratio is 1:3. Finally, we did not contact the patients after ICU discharge to determine whether there were improvements in post-ICU quality of life and rehabilitation relative to the data reported by Desbiens and the SUPPORT group (34, 39) .
CONCLUSIONS
Systematic evaluation of pain and agitation levels by nurses using the BPS, the ICU-adapted large size NRS, and the RASS following by a medical intervention after initial nurse and physician education on pain and agitation management is associated with a decrease in the incidence and intensity of these events in ICU. In addition, this improvement process in quality and safety is associated with a decrease in duration of sedation, duration of ventilation, and nosocomial infections rate. These results could be explained by a better match between analgesic and psychoactive drugs administered and patients' requirements. 
